2026 interim results
The Group delivered a strong performance, with earnings per share (EPS) increasing by 18% to 348 cents per share (H1 2025: 294 cents per share). The increase was driven by operating profitability and lower net finance costs, reflecting the benefit of reduced debt levels. Headline earnings per share (HEPS) rose by 8% to 653 cents per share (H1 2025: 604 cents per share), after accounting for impairment charges of R330 million, mainly relating to AECI Schirm Germany (H1 2025: R337 million).
Revenue from continuing operations declined by 4% to R15,073 million (H1 2025: R15,689 million) mainly as a result of revenues in AECI Chemicals. Prior year comparative results included revenue amounting to R1,055 million on businesses that have been disposed and , when normalised, resulted in a 3% increase in revenue.
Profit from continuing operations increased by 20% to R837 million (H1 2025: R699 million), driven by lower operational costs, depreciation and amortisation, following the disposal of non-core business.
Depreciation, amortisation and impairments decreased by 13% to R760 million (H1 2025: R870 millions) primarily due to the exclusion of businesses that were disposed of in H2 2025. An impairment charge of R330 million mainly related to an out-of-period impairment assessment at AECI Schirm Germany was recorded for the period.
Profit from operations
R 837m (up 20%)
H1 2025: R 699m
Headline earnings per share (HEPS)
653 cents (up 8%)
H1 2025: 604 cents
Cash dividend
116 cents per share (up 16%)
